Tag Archives: UK MEDICINAL

Medicinal Cannabis: What Does the Science Say? | Jamie George

JAMIE GEORGE Wed 31 Oct 2018 19.44 GMT  Last modified on Thurs 1st Nov 2018 07.32 GMTFrom today (November 1st), doctors in the UK will, for the first time, be legally allowed to prescribe medical cannabis to their patients. The shift in policy was announced in July by home secretary Sajid Javid following the prominent media attention given to the cases of

Read more

MEDICAL CANNABIS IS NOW LEGAL IN THE UK, BUT WHAT CAN WE EXPECT?

November 1, 2018 Medical cannabis is officially available in the UK today via prescription and millions of patients, who suffer from registered conditions that can be treated with cannabis, could qualify for treatment. Access will remain restricted in the short-term but is expected to expand as the number of clinicians listed on the Specialist Register of the General Medical Council

Read more

Minister starts the debate on Drugs announcing she cannot talk about Cannabis!

Has anyone got any comments they would like to add to this absurd and laughable response? Are @UKParliament, @HouseofCommons, @UKHouseofLords trying to put the Economy in reverse? Surely not!! England needs to move forward fast @CLEARUK #cannabis #canada #news Quote from Ronnie Cowan MP:  “My drugs policy debate in @HouseofCommons has just finished. However, interesting to note the Minister had

Read more

Can UK farmers benefit from the upcoming medical cannabis?

Source: http://www.weedworldmagazine.org Cannabis will become an international commodity, but only a limited number will get to cultivate it With the UK Government moving towards legalizing medicinal cannabis could this be an opportunity for the UK farmers to diversify? This autumn will see specialist doctors prescribing medicinal cannabis for the first time in the UK. Could this decision be behind an

Read more

UK developer of medical cannabis products raises $345m through share sale

Source: The Pharmaceutical Journal9 OCT 2018By Debbie Andalo UK-based GW Pharmaceuticals has sold almost two million shares in a recent offering on the US stock exchange. Source: GW Pharmaceuticals GW Pharmaceuticals, which has previously marketed cannabis-derived medicines Sativex and Epidiolex, has raised over $345m from share sales in the United States The UK biopharmaceutical company GW Pharmaceuticals, a global developer of

Read more